|
Nov 9
|
Cue Biopharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights
|
|
Nov 7
|
Cue Biopharma to Present at Three Upcoming Investor Healthcare Conferences in November
|
|
Nov 3
|
Cue Biopharma Presents New Positive Data from Phase 1 Trials of CUE-101 in Head and Neck Cancer and CUE-102 in Wilms’ Tumor 1 Positive Cancers at SITC 2023
|
|
Nov 2
|
Cue Biopharma to Host Business Update Call and Webcast
|
|
Apr 25
|
Cue Biopharma Welcomes Seasoned Pharmaceutical Executive Pamela D. Garzone, Ph.D., to its Board of Directors
|